Supplementary Table 3 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

Zhe Lei,Reng-Yun Liu,Jun Zhao,Zeyi Liu,Xiefang Jiang,Weiming You,Xiao-Feng Chen,Xia Liu,Kui Zhang,Boris Pasche,Hong-Tao Zhang

DOI: https://doi.org/10.1158/0008-5472.22379141

2023-01-01

Abstract:Supplementary Table 3 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

What problem does this paper attempt to address?

Supplementary Table 1 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

Zhe Lei,Reng-Yun Liu,Jun Zhao,Zeyi Liu,Xiefang Jiang,Weiming You,Xiao-Feng Chen,Xia Liu,Kui Zhang,Boris Pasche,Hong-Tao Zhang

DOI: https://doi.org/10.1158/0008-5472.22379147

2023-01-01

Abstract:Supplementary Table 1 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer
Supplementary Table 2 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

Zhe Lei,Reng-Yun Liu,Jun Zhao,Zeyi Liu,Xiefang Jiang,Weiming You,Xiao-Feng Chen,Xia Liu,Kui Zhang,Boris Pasche,Hong-Tao Zhang

DOI: https://doi.org/10.1158/0008-5472.22379144

2023-01-01

Abstract:Supplementary Table 2 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer
Tgfbr1 Haplotypes and Risk of Non-Small-Cell Lung Cancer

Zhe Lei,Reng-Yun Liu,Jun Zhao,Zeyi Liu,Xiefang Jiang,Weiming Yu,Xiao-Feng Chen,Xia Liu,Kui Zhang,Boris Pasche,Hong-Tao Zhang

DOI: https://doi.org/10.1158/0008-5472.can-08-4602

IF: 11.2

2009-01-01

Cancer Research

Abstract:Transforming growth factor beta (TGF-beta) receptors are centrally involved in TGF-beta-mediated cell growth and differentiation and are frequently inactivated in non-small-cell lung cancer (NSCLC). Constitutively decreased type I TGF-beta receptor (TGFBR1) expression is emerging as a novel tumor-predisposing phenotype. The association of TGFBR1 haplotypes with risk for NSCLC has not yet been studied. We tested the hypothesis that single-nucleotide polymorphisms (SNP) and/or TGFBR1 haplotypes are associated with risk of NSCLC. We genotyped six TGFBR1 haplotype-tagging SNPs (htSNP) by PCR-RFLP assays and one htSNP by PCR-single-strand conformation polymorphism assay in two case-control studies. Case-control study 1 included 102 NSCLC patients and 104 healthy controls from Suzhou. Case-control study 2 included 131 patients with NSCLC and 133 healthy controls from Wuxi. Individuals included in both case-control studies were Han Chinese. Haplotypes were reconstructed according to the genotyping data and linkage disequilibrium status of these seven htSNPs. None of the htSNP was associated with NSCLC risk in either study. However, a four-marker CTGC haplotype was significantly more common among controls than among cases in both studies (P = 0.014 and P = 0.010, respectively), indicating that this haplotype is associated with decreased NSCLC risk {adjusted odds ratio [OR], 0.09 [95% confidence interval (95% CI), 0.01-0.61] and 0.11 [95% CI, 0.02-0.59], respectively}. Combined analysis of both studies shows a strong association of this four-marker haplotype with decreased NSCLC risk (adjusted OR, 0.11; 95% CI, 0.03-0.39). This is the first evidence of an association between a TGFBR1 haplotype and risk for NSCLC.
Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Pengyuan Liu,Haris G. Vikis,Yan Lu,Yian Wang,Ann G. Schwartz,Susan M. Pinney,Ping Yang,Mariza de Andrade,Adi Gazdar,Colette Gaba,Diptasri Mandal,Juwon Lee,Elena Kupert,Daniela Seminara,John Minna,Joan E. Bailey-Wilson,Christopher I. Amos,Marshall W. Anderson,Ming You

DOI: https://doi.org/10.1158/1055-9965.22435836.v1

2023-01-01

Abstract:Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer
Supplementary Table 4 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Rui Wang,Lei Wang,Yuan Li,Haichuan Hu,Lei Shen,Xuxia Shen,Yunjian Pan,Ting Ye,Yang Zhang,Xiaoyang Luo,Yiliang Zhang,Bin Pan,Bin Li,Hang Li,Jie Zhang,William Pao,Hongbin Ji,Yihua Sun,Haiquan Chen

DOI: https://doi.org/10.1158/1078-0432.22461768

2023-01-01

Abstract:Independent predictors of FGFR1/3 fusions in 1328 patients with NSCLCs in multivariate analysis
Supplementary Table 5 and 6 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Rui Wang,Lei Wang,Yuan Li,Haichuan Hu,Lei Shen,Xuxia Shen,Yunjian Pan,Ting Ye,Yang Zhang,Xiaoyang Luo,Yiliang Zhang,Bin Pan,Bin Li,Hang Li,Jie Zhang,William Pao,Hongbin Ji,Yihua Sun,Haiquan Chen

DOI: https://doi.org/10.1158/1078-0432.22461762.v1

2023-01-01

Abstract:Table 5:Correlation between FGFR fusion and expression Table 6: Clinicopathologic Characteristics of 734 Patients with NSCLC in Survival analysis
Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15Q24-25.1

Yan Liu,Pengyuan Liu,Weidong Wen,Michael A. James,Yian Wang,Joan E. Bailey-Wilson,Christopher I. Amos,Susan M. Pinney,Ping Yang,Mariza de Andrade,Gloria M. Petersen,Jonathan S. Wiest,Pamela R. Fain,Ann G. Schwartz,Adi Gazdar,Colette Gaba,Henry Rothschild,Diptasri Mandal,Elena Kupert,Juwon Lee,Daniela Seminara,John Minna,Marshall W. Anderson,Ming You

DOI: https://doi.org/10.1158/0008-5472.22382063

2023-01-01

Abstract:Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Supplementary Table 3 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Rui Wang,Lei Wang,Yuan Li,Haichuan Hu,Lei Shen,Xuxia Shen,Yunjian Pan,Ting Ye,Yang Zhang,Xiaoyang Luo,Yiliang Zhang,Bin Pan,Bin Li,Hang Li,Jie Zhang,William Pao,Hongbin Ji,Yihua Sun,Haiquan Chen

DOI: https://doi.org/10.1158/1078-0432.22461774.v1

2023-01-01

Abstract:Clinicopathologic Characteristics in NSCLC Patients with FGFR, ALK, RET and ROS1 fusions
Supplementary Table 1-3 from MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients

Xia Pu,Jack A. Roth,Michelle A.T. Hildebrandt,Yuanqing Ye,Hua Wei,John D. Minna,Scott M. Lippman,Xifeng Wu

DOI: https://doi.org/10.1158/0008-5472.22399995.v1

2023-01-01

Abstract:Supplementary Table 1-3 PDF file - 162K, Supplementary tables 1 and 2 include effect of selected SNPs on overall survival or recurrence in early stage NSCLC patients; Supplementary table 3 includes all the SNPs selected in the analysis
Supplementary Table 5 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Rui Wang,Lei Wang,Yuan Li,Haichuan Hu,Lei Shen,Xuxia Shen,Yunjian Pan,Ting Ye,Yang Zhang,Xiaoyang Luo,Yiliang Zhang,Bin Pan,Bin Li,Hang Li,Jie Zhang,William Pao,Hongbin Ji,Yihua Sun,Haiquan Chen

DOI: https://doi.org/10.1158/1078-0432.22461759.v1

2023-01-01

Abstract:PDF file - 56KB, Correlation between FGFR fusion and expression.
Supplementary Tables 1 - 3 from Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study

Xia Pu,Yuanqing Ye,Margaret R. Spitz,Liang Wang,Jian Gu,Scott M. Lippman,Michelle A.T. Hildebrandt,Waun Ki Hong,John D. Minna,Jack A. Roth,Ping Yang,Xifeng Wu

DOI: https://doi.org/10.1158/1078-0432.22446162

2023-01-01

Abstract:PDF file - 83k, Supplementary Table 1: Inflammation-related pathways selected in this study Supplementary Table 2: Effect of selected SNPs on survival in adenocarcinoma female patients Supplementary Table 3: Effect of selected SNPs on survival duration in patients with late-stage lung cancer Supplementary Table 4: Effect of selected SNPs on survival duration in patients by gender
Relationship between genetic susceptibility of non-small ceil lung cancer and the TGF-βRI gene

Lei Hong,Shi-ying Zheng,Jun Zhao

2008-01-01

Abstract:Objective To investigate whether the transforming growth factor-beta receptor type I (TGF-βRI) gene is associated with genetic predisposition of primary non-small cell lung cancer (NSCLC). Methods The entire coding region of TGF-βRI and flanking intron sequences from 53 NSCLC tissues were examined for alterations using SSCP and direct sequencing. Results No somatic point muta-tions other than two silent mutations and a polymorphism were found in the TGF-βRI gene. The two silent mutations located at codon 544 (AAT to AAC) and codon 406 (TrA to CTA) ,respectively,and the poly-morphism was at 24 th base of intron7 (G to A). Interestingly,we found that the subjects with homozygous genotype A/A displayed more than threefold increased risk of developing NSCLC than the common wild genotype G/G. Conclusion As the first report,this study showed that TGF-βRI gene is not a frequent site of spontaneous mutational inactivation while the detected polymorphism could be a susceptibility allele that predisposes to carcinogenesis of NSCLC. Key words: TGF-βRI; NSCLC; Mutation; Polymorphism
A Haplotype of Tgfbr1 is Predominantly Found in Non-Small Cell Lung Cancer Patients Displaying Tgfbr1 Allelic-Specific Expression

Jinxia Sun,Zhe Lei,Reng-Yun Liu,Yufeng Lu,Zhixiang Zhuang,Xiefang Jiang,Qian,Zeyi Liu,Jun Zhao,Hong-Tao Zhang

DOI: https://doi.org/10.3892/or.2011.1135

2011-01-01

Oncology Reports

Abstract:Non-small cell lung cancer (NSCLC) accounts for ~85% of all cases of lung cancer and TGF-ß refractoriness is very common in NSCLC cells. Constitutively decreased TGFBR1 expression, probably leading to TGF-ß resistance in tumors, is emerging as a novel tumor-predisposing phenotype. However, the precise genetic/epigenetic mechanisms underlying the role of TGFBR1 in NSCLC carcinogenesis are still largely unknown. In the present study, we performed the SNaPshot method to quantify allelic-specific expression (ASE) of two chosen SNPs that are located in the 3' untranslated region (3' UTR) of the TGFBR1 gene. We selected seven tagging SNPs (tSNPs) of TGFBR1 to assess the relationship between ASE of TGFBR1 and tSNP-reconstructed haplotypes in NSCLC tumors. ASE of TGFBR1 was detected in 21.1% of NSCLC tumors. One tagging SNP (rs7040869) of TGFBR1 in the 5' flanking region was found to be significantly associated with TGFBR1 ASE in NSCLC tumors (P=0.03). A 2-tSNP AT haplotype reconstructed with tSNP rs7040869 and rs4743325, in linkage disequilibrium with each other, was strongly associated with NSCLC cases displaying ASE (P=0.01). In conclusion, our results shed light on the high frequency of TGFBR1 ASE phenotype in NSCLC tumors, which is associated with the 2-tSNP haplotype of the TGFBR1 gene. Although this suggests an important role of the TGFBR1 locus in the etiology of NSCLC, additional studies at the germline level and in various ethnic populations are warranted.
No association between TGFBR1*6A and lung cancer.

Weiming You,Zeyi Liu,Jun Zhao,Mingfeng Zheng,Shi-Ying Zheng,Xia Liu,Hong-Tao Zhang

DOI: https://doi.org/10.1097/JTO.0b013e318070ccd7

IF: 20.121

2007-01-01

Journal of Thoracic Oncology

Abstract:TGFBR1*6A, a functionally polymorphic allele in the transforming growth factor [beta] receptor 1 gene (TGFBR1), has been hypothesized to increase risk of various cancers. However, little has been documented about connection of this variant with lung cancer.In an attempt to explore whether the TGFBR1*6A is associated with lung cancer, we performed genotyping followed by sequencing in 252 patients with lung cancer and 250 healthy controls.The frequency for the heterozygote 9A/6A is 13.9% in cases compared with 12.4% in controls, and the odds ratio is 1.14 (95% confidence interval: 0.68-1.91), which is not statistically significant (p = 0.62), suggesting that TGFBR1*6A could not be a cancer susceptibility factor for Chinese patients with lung cancer.We have no evidence to support the hypothesis that TGFBR1*6A is associated with lung cancer.
Supplementary Figure 3 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Rui Wang,Lei Wang,Yuan Li,Haichuan Hu,Lei Shen,Xuxia Shen,Yunjian Pan,Ting Ye,Yang Zhang,Xiaoyang Luo,Yiliang Zhang,Bin Pan,Bin Li,Hang Li,Jie Zhang,William Pao,Hongbin Ji,Yihua Sun,Haiquan Chen

DOI: https://doi.org/10.1158/1078-0432.22461795

2023-01-01

Abstract:Kaplan-Meier survival curves for relapse free and overall survival according to EGFR, KRAS, BRAF, HER2, FGFR or wild-type status
Genome-wide haplotype association study identifies risk genes for non-small cell lung cancer

Yanbo Teng,Yanjun Ding,Mingming Zhang,Xinren Chen,Xizi Wang,Hang Yu,Chonghui Liu,Hongchao Lv,Ruijie Zhang

DOI: https://doi.org/10.1016/j.jtbi.2018.08.007

2018-11-07

Abstract:Lung cancer is the leading cause of cancer-related death worldwide. Most lung cancer is non-small cell lung cancer (NSCLC), in which malignant cells form in the lung epithelium. Mutations in multiple genes and environmental factors both contribute to NSCLC, and although some NSCLC susceptibility genes have been characterized, the pathogenesis of this disease remains unclear. To identify genes conferring NSCLC risk and determine their associated pathological mechanism, we combined genome-wide haplotype associated analysis with gene prioritization using 224,677 SNPs in 37 NSCLC cell lines and 116 unrelated European individuals. Five candidate genes were identified: ESR1, TGFBR1, INSR, CDH3, and MAP3K5. All of these have previously been implicated in NSCLC, with the exception of CDH3, which can therefore be considered a novel indicator of NSCLC risk. Functional annotation confirmed the relationship between these five genes and NSCLC. Our findings are indicative of the underlying pathological mechanisms of NSCLC and provide information to support future directions in diagnosing and treating NSCLC.
Supplementary Figure 1 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Rui Wang,Lei Wang,Yuan Li,Haichuan Hu,Lei Shen,Xuxia Shen,Yunjian Pan,Ting Ye,Yang Zhang,Xiangfeng Luo,Yiliang Zhang,Bin Peng,Bin Li,Hang Li,Jie Zhang,William Pao,Hongbin Ji,Yu Sun,Haiquan Chen

DOI: https://doi.org/10.1158/1078-0432.22461807.v1

2023-01-01

Abstract:FGFR3-TACC3 fusion variants and BAG4-FGFR1 fusion in NSCLCs
Supplementary Figures 1-2, Tables 1-6 from Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations

Chen Wu,Zhibin Hu,Dianke Yu,Liming Huang,Guangfu Jin,Jie Liang,Huan Guo,Wen Tan,Mingfeng Zhang,Ji Qian,Daru Lu,Tangchun Wu,Dongxin Lin,Hongbing Shen

DOI: https://doi.org/10.1158/0008-5472.22377476.v1

2023-01-01

Abstract:Supplementary Figures 1-2, Tables 1-6 from Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations
TGFβ1 Gene Polymorphisms with the Risk of Radiation Pneumonitis in Non-Small Cell Lung Cancer in Different Ethnic Study.

X. Niu,S. Lu,H. Li,Y. Liu,Z. Chen,D. Zhou,M. Kan,Z. Li,Y. Yu,C. LV

DOI: https://doi.org/10.1200/jco.2011.29.15_suppl.10606

IF: 45.3

2011-01-01

Journal of Clinical Oncology

Abstract:10606 Background: To investigate whether non–small-cell lung cancer (NSCLC) patients in Chinese with risk of radiation pneumonitis (RP) (grade≥3) by radiotherapy display reliable single nucleotide polymorphisms (SNPs) marker(s) located in transforming growth factor 1 (TGFβ1) gene. Methods: DNA was isolated from blood samples obtained from NSCLC patients (n=167) treated with deﬁnitive radiotherapy alone (n=125) or concurrent chemoradiation (n=42). Eight SNPs of the TGFβ1 gene (rs1800469, rs1800471, rs1982073, rs4803455, rs11466345, rs12983047, rs10417924, and rs10980942) were genotyped by direct DNA sequencing method. Kaplan-Meier cumulative probability was used to assess the risk of grade≥3 RP and Cox proportional hazards analysis to evaluate the effect of TGFβ1 genotypes on such risk. Results: There were 125 men and 42 women in the study with median age of 58 years. 53 (31.7%) patients developed grade 2 RP, 46 (27.5%) developed grade≥3 RP, respectively, based on CTCAEv3.0. SNP rs1982073 with RP risk in Caucasians was failed to validate to associate with the risk of grade≥3 RP in Chinese NSCLC patients. Multivariate analysis found AG/GG genotypes of novel TGFβ1 rs11466345 to be associated with a statistically signiﬁcantly higher risk of RP grades≥3 (HR=2.295; 95% CI, 1.101 to 4.783; P=0.027), compared with the AA genotype, after adjustment for age, smoking status, and dosimetric parameters. Conclusions: Our results showed that AG/GG genotypes of novel TGFβ1 rs11466345 were associated with higher risk of RP in Chinese NSCLC patients treated with radiotherapy. Further studies are warranted to confirm these findings in different ethnic populations.
A Study of Ethnic Differences in TGFβ1 Gene Polymorphisms and Effects on the Risk of Radiation Pneumonitis in Non–Small-Cell Lung Cancer

Xiaomin Niu,Hongxuan Li,Zhiwei Chen,Yun Liu,Mengyuan Kan,Daizhan Zhou,Ziming Li,Xiangyun Ye,Shengping Shen,Changxing Lv,Shun Lu

DOI: https://doi.org/10.1097/jto.0b013e318267cf5b

IF: 20.121

2012-01-01

Journal of Thoracic Oncology

Abstract:Background: To investigate whether Chinese non-small-cell lung cancer (NSCLC) patients with risk of radiation pneumonitis (RP) (grade >= 3) caused by radiotherapy display reliable single-nucleotide polymorphism (SNP) marker(s) located on the transforming growth factor-beta-1 (TGF beta 1) gene.Methods: DNA was isolated from blood samples obtained from NSCLC patients (n = 167) treated with radiotherapy alone (n = 23) or chemoradiation (n = 144) with the median total radiation dose of 56 Gy between 2007 and 2010. A comprehensive approach toward characterizing the TGF beta 1 SNPs in Chinese patients was carried out in this study. Eight SNPs of the TGF beta 1 gene (rs1800469, rs1800471, rs1982073, rs4803455, rs11466345, rs12983047, rs10417924, and rs10980942) were finally genotyped by the direct DNA sequencing method. Kaplan-Meier cumulative probability was used to assess the risk of RP of grade 3 or higher. Cox proportional hazard analysis was used to evaluate the effect of TGF beta 1 genotypes on RP risk.Results: A total of 46 patients (27.5%) developed RP of grade 3 or higher, based on Common Terminology Criteria for Adverse Events version 3.0, with a median follow-up of 29.5 months (range, 16-58). The rs1982073 SNP, associated with RP risk in whites, was not found to be associated with the risk of RP of grade 3 or higher in Chinese NSCLC patients. Multivariate analysis found AG/GG genotypes of the novel TGF beta 1 SNP rs11466345 to be associated with a significantly higher risk of RP of grade 3 or higher compared with the AA genotypes, after adjustment for age, smoking status, and dosimetric parameters (for mean lung dose, adjusted hazards ratio = 2.295, 95% confidence interval: 1.101-4.783, p = 0.027; for volume of normal lung receiving 20 GY or more radiation, adjusted hazards ratio = 2.142, 95% confidence interval: 1.033-4.441, p = 0.041).Conclusion: The AG/GG genotypes of novel TGF beta 1 rs11466345 were associated with a higher risk of RP in Chinese NSCLC patients treated with radiotherapy. The rs1982073 SNP, associated with RP risk in whites, was not correlated with higher RP risk in the Chinese patients studied. Further studies are warranted to confirm these findings in different ethnic populations.

Supplementary Table 3 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

Supplementary Table 1 from <i>TGFBR1</i> Haplotypes and Risk of Non–Small-Cell Lung Cancer

Supplementary Table 2 from <i>TGFBR1</i> Haplotypes and Risk of Non–Small-Cell Lung Cancer

Tgfbr1 Haplotypes and Risk of Non-Small-Cell Lung Cancer

Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Supplementary Table 4 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Supplementary Table 5 and 6 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15Q24-25.1

Supplementary Table 3 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Supplementary Table 1-3 from MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients

Supplementary Table 5 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Supplementary Tables 1 - 3 from Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study

Relationship between genetic susceptibility of non-small ceil lung cancer and the TGF-βRI gene

A Haplotype of Tgfbr1 is Predominantly Found in Non-Small Cell Lung Cancer Patients Displaying Tgfbr1 Allelic-Specific Expression

No association between TGFBR1*6A and lung cancer.

Supplementary Figure 3 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Genome-wide haplotype association study identifies risk genes for non-small cell lung cancer

Supplementary Figure 1 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Supplementary Figures 1-2, Tables 1-6 from Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations

TGFβ1 Gene Polymorphisms with the Risk of Radiation Pneumonitis in Non-Small Cell Lung Cancer in Different Ethnic Study.

A Study of Ethnic Differences in TGFβ1 Gene Polymorphisms and Effects on the Risk of Radiation Pneumonitis in Non–Small-Cell Lung Cancer

Supplementary Table 3 from TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer

Supplementary Table 1 from &lt;i&gt;TGFBR1&lt;/i&gt; Haplotypes and Risk of Non–Small-Cell Lung Cancer

Supplementary Table 2 from &lt;i&gt;TGFBR1&lt;/i&gt; Haplotypes and Risk of Non–Small-Cell Lung Cancer

Tgfbr1 Haplotypes and Risk of Non-Small-Cell Lung Cancer

Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Supplementary Table 4 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Supplementary Table 5 and 6 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Supplementary Figure 1 from Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15Q24-25.1

Supplementary Table 3 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Supplementary Table 1-3 from MicroRNA-Related Genetic Variants Associated with Clinical Outcomes in Early-Stage Non–Small Cell Lung Cancer Patients

Supplementary Table 5 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Supplementary Tables 1 - 3 from Predictors of Survival in Never-Smokers with Non–Small Cell Lung Cancer: A Large-Scale, Two-Phase Genetic Study

Relationship between genetic susceptibility of non-small ceil lung cancer and the TGF-βRI gene

A Haplotype of Tgfbr1 is Predominantly Found in Non-Small Cell Lung Cancer Patients Displaying Tgfbr1 Allelic-Specific Expression

No association between TGFBR1*6A and lung cancer.

Supplementary Figure 3 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Genome-wide haplotype association study identifies risk genes for non-small cell lung cancer

Supplementary Figure 1 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Supplementary Figures 1-2, Tables 1-6 from Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations

TGFβ1 Gene Polymorphisms with the Risk of Radiation Pneumonitis in Non-Small Cell Lung Cancer in Different Ethnic Study.

A Study of Ethnic Differences in TGFβ1 Gene Polymorphisms and Effects on the Risk of Radiation Pneumonitis in Non–Small-Cell Lung Cancer

Supplementary Table 1 from <i>TGFBR1</i> Haplotypes and Risk of Non–Small-Cell Lung Cancer

Supplementary Table 2 from <i>TGFBR1</i> Haplotypes and Risk of Non–Small-Cell Lung Cancer